Ways to Manage Your Health, Finances, and More
May 20, 2020
Check out Direct Energy, Truebill, V Shred, and Proofread Anywhere
We’re back with a new episode of The Balancing Act. We’re diving into ways to earn money at home and tips to stay healthy, as well as how Direct Energy is working to protect your home.
Ready to learn the secrets of working from home – or anywhere in the world? Due to the coronavirus pandemic, more people than ever before are homebound. Many are working remotely, while others have been furloughed or laid off. That’s why we’re sitting down with founder/CEO of Proofread Anywhere Caitlin Pyle to discuss ways to successfully work from home.
Direct Energy is one of North America’s largest retail providers of electricity, natural gas, and energy-related services for homes and businesses. With nearly four million customers, they provide choice, simplicity, and innovation where energy, data, and technology meet. CEO Bruce Stewart gives us ways we can conserve energy during the pandemic.
V Shred is the fastest growing fitness, nutrition, and supplement brand in the world. They have created some of the world’s most popular and highest selling workout and nutrition programs. Stay tuned to learn more.
Now more than ever, we are all looking at ways to cut costs by lowering bills, canceling unwanted subscriptions, and more. Enter Truebill, a budget and bill tracker app that helps you take control of your finances.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.